The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[(2-methyl-1H-indol-3-yl)-(4-methylsulfanylphenyl)methyl]pyridin-2-amine ID: ALA5189912
PubChem CID: 3447990
Max Phase: Preclinical
Molecular Formula: C22H21N3S
Molecular Weight: 359.50
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CSc1ccc(C(Nc2ccccn2)c2c(C)[nH]c3ccccc23)cc1
Standard InChI: InChI=1S/C22H21N3S/c1-15-21(18-7-3-4-8-19(18)24-15)22(25-20-9-5-6-14-23-20)16-10-12-17(26-2)13-11-16/h3-14,22,24H,1-2H3,(H,23,25)
Standard InChI Key: BULDSMXGVHSVEQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
0.4665 2.0334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1811 2.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8930 2.0338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8930 1.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1829 0.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4665 1.2050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3408 0.9537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8135 1.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3195 2.2803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6387 1.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5543 0.1566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0290 -0.4267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3514 -0.0568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5650 -0.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9817 -1.4375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1953 -2.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9926 -2.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5743 -1.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3655 -1.0683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8262 -0.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4074 -0.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1938 -1.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4010 -1.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1854 -1.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7773 -2.1764 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5743 -1.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
7 8 2 0
9 8 1 0
1 9 1 0
8 10 1 0
7 11 1 0
11 12 1 0
11 13 1 0
13 14 1 0
15 14 2 0
16 15 1 0
17 16 2 0
18 17 1 0
19 18 2 0
14 19 1 0
20 12 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
12 24 1 0
22 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.50Molecular Weight (Monoisotopic): 359.1456AlogP: 5.79#Rotatable Bonds: 5Polar Surface Area: 40.71Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.52CX LogP: 5.26CX LogD: 5.21Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: -1.33
References 1. Feng X, Yan Z, Zhou F, Lou J, Lyu X, Ren X, Zeng Z, Liu C, Zhang S, Zhu D, Huang H, Yang J, Zhao Y.. (2022) Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells., 236 [PMID:35385805 ] [10.1016/j.ejmech.2022.114327 ] 2. Li X, Dou J, You Q, Jiang Z.. (2021) Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy., 220 [PMID:34034128 ] [10.1016/j.ejmech.2021.113539 ]